Bruker (BRKR) Notes Payables (2010 - 2025)

Bruker (BRKR) has reported Notes Payables for 15 consecutive years, with $39.1 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Notes Payables rose 4244.44% year-over-year to $39.1 million; the trailing twelve-month figure through Dec 2025 stood at $39.1 million (up 4244.44% YoY), and the FY2025 full-year result was $39.1 million, up 4244.44% from the prior year.
• Notes Payables rose to $39.1 million in Q4 2025 per BRKR's latest filing, from $900000.0 in the prior quarter.
• Across five years, Notes Payables topped out at $39.1 million in Q4 2025 and bottomed at $900000.0 in Q4 2022.
• Historically, Notes Payables has averaged $9.6 million across 5 years, with a median of $900000.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Notes Payables slumped 85.94% in 2022, then jumped 4244.44% in 2025.
• Over 5 years, Notes Payables stood at $6.4 million in 2021, then plunged by 85.94% to $900000.0 in 2022, then changed by 0.0% to $900000.0 in 2023, then changed by 0.0% to $900000.0 in 2024, then surged by 4244.44% to $39.1 million in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $39.1 million, $900000.0, and $900000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.